• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Focus areas
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Focus areas
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesFocus areasTry Devex Pro
    • News
    • Global health

    What PEPFAR's political paralysis means for the Global Fund

    PEPFAR's authorizing legislation expired on Sept. 30. While the flagship U.S. global AIDS program's work will continue, experts warn the ongoing political stalemate could have knock-on effects for PEPFAR's multilateral partner.

    By Michael Igoe // 27 October 2023
    Advocates for the United States global AIDS relief program PEPFAR are urging supporters not to panic about the political battle that has prevented the initiative’s reauthorization in the U.S. Congress. While that legislation is important, they say, the program will continue operating without it. “Just because it hasn't been reauthorized doesn't mean it ends,” Jennifer Kates, director of global health and HIV policy at KFF, said in a webinar on Thursday. “PEPFAR is a permanent part of U.S. law. As long as it continues to be funded by Congress, it continues.” PEPFAR’s current five-year authorization expired at the end of the fiscal year on Sept. 30 in the midst of a bitter fight over allegations from some Republicans that President Joe Biden’s administration has co-opted the initiative as part of a liberal social agenda that promotes abortion. While PEPFAR’s work continues without that legislative support in place, some of the specific policies embedded in the previous authorizing bill did expire alongside it. One of those policies governs U.S. government funding for the Global Fund to Fight AIDS, Tuberculosis and Malaria, a multilateral organization that works alongside PEPFAR in dozens of countries. Previous PEPFAR reauthorization bills have stipulated that the U.S. government can only contribute 33% of the Global Fund’s three-year financial replenishment, which supporters view as an important policy for compelling ambitious contributions from other donors. While this provision places a limit on the United States’ contribution to the Global Fund, it has also created a norm that the U.S. will contribute the maximum allowable amount, Mark Lagon, chief policy officer at Friends of the Global Fight, said Thursday. “There's a very clear record of other countries stepping up with us because they know that they'll be leaving U.S. money on the table if they don't step up,” Lagon said. That provision is most effective when it is part of a five-year PEPFAR authorization bill that allows for long-term budgetary planning and advocacy, Lagon said. He added that a one- or two-year reauthorization — which some critics have proposed as a stopgap — would result in a “markedly weakened” ability to lean on other countries to increase their contributions — even if the U.S. government ends up contributing its full amount. “There are a lot of downsides to not having a multiyear reauthorization that's clean, that doesn't make any changes or break open earlier compromises,” Lagon said. On Thursday, the Washington Post reported that Republican lawmakers are preventing PEPFAR from spending more than $1 billion that lawmakers already approved for the initiative by placing “holds” on congressional notifications that are required for money to be released. “The delays in approval are straining PEPFAR country operations and threatening PEPFAR’s ability to continue implementation,” the State Department said in a statement to the Post. “I would posit that that is a more serious challenge right now than the fact that we passed September 30th without a reauthorization and the fact that we don't have a budget yet,” Kates said Thursday.

    Related Stories

    How will America's new global health strategy change PEPFAR?
    How will America's new global health strategy change PEPFAR?
    US lawmakers propose sweeping State Department reforms
    US lawmakers propose sweeping State Department reforms
    Exclusive: Senate Democrats introduce bill to protect UN Population Fund
    Exclusive: Senate Democrats introduce bill to protect UN Population Fund
    Devex Pro Insider: The $6.5B US foreign aid spending spree
    Devex Pro Insider: The $6.5B US foreign aid spending spree

    Advocates for the United States global AIDS relief program PEPFAR are urging supporters not to panic about the political battle that has prevented the initiative’s reauthorization in the U.S. Congress.

    While that legislation is important, they say, the program will continue operating without it.

    “Just because it hasn't been reauthorized doesn't mean it ends,” Jennifer Kates, director of global health and HIV policy at KFF, said in a webinar on Thursday. “PEPFAR is a permanent part of U.S. law. As long as it continues to be funded by Congress, it continues.”

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    More reading:

    ► Abortion politics cast shadow over PEPFAR reauthorization

    ► What ‘extremism’ in US politics means for PEPFAR’s future (Pro)

    ► Could faith groups face backlash from PEPFAR's abortion battle?

    • Global Health
    • Trade & Policy
    • Funding
    • Democracy, Human Rights & Governance
    • The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)
    • U.S. President's Emergency Plan for AIDS Relief (PEPFAR)
    • United States
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Michael Igoe

      Michael Igoe@AlterIgoe

      Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.

    Search for articles

    Related Stories

    The Future of Global HealthRelated Stories - How will America's new global health strategy change PEPFAR?

    How will America's new global health strategy change PEPFAR?

    The Trump EffectRelated Stories - US lawmakers propose sweeping State Department reforms

    US lawmakers propose sweeping State Department reforms

    Global HealthRelated Stories - Exclusive: Senate Democrats introduce bill to protect UN Population Fund

    Exclusive: Senate Democrats introduce bill to protect UN Population Fund

    Devex Pro InsiderRelated Stories - Devex Pro Insider: The $6.5B US foreign aid spending spree

    Devex Pro Insider: The $6.5B US foreign aid spending spree

    Most Read

    • 1
      Ending HIV globally requires action in Eastern Europe and Central Asia
    • 2
      One year on: Is Africa’s surgical equity push delivering real change?
    • 3
      What will it take to unlock private financing in a changing era?
    • 4
      US launches $4.5B platform inviting NGO support for bilateral health deals
    • 5
      How to deliver results at scale for people and planet
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2026 Devex|User Agreement|Privacy Statement